A timeline of tumour-associated macrophage biology
L Cassetta, JW Pollard - Nature Reviews Cancer, 2023 - nature.com
Tumour progression is modulated by the local microenvironment. This environment is
populated by many immune cells, of which macrophages are among the most abundant …
populated by many immune cells, of which macrophages are among the most abundant …
Glioma targeted therapy: insight into future of molecular approaches
Gliomas are the common type of brain tumors originating from glial cells. Epidemiologically,
gliomas occur among all ages, more often seen in adults, which males are more susceptible …
gliomas occur among all ages, more often seen in adults, which males are more susceptible …
Harnessing nanomaterials for cancer sonodynamic immunotherapy
Immunotherapy has made remarkable strides in cancer therapy over the past decade.
However, such emerging therapy still suffers from the low response rates and immune …
However, such emerging therapy still suffers from the low response rates and immune …
The spatial landscape of progression and immunoediting in primary melanoma at single-cell resolution
Cutaneous melanoma is a highly immunogenic malignancy that is surgically curable at early
stages but life-threatening when metastatic. Here we integrate high-plex imaging, 3D high …
stages but life-threatening when metastatic. Here we integrate high-plex imaging, 3D high …
Adipocyte-derived kynurenine promotes obesity and insulin resistance by activating the AhR/STAT3/IL-6 signaling
T Huang, J Song, J Gao, J Cheng, H Xie… - Nature …, 2022 - nature.com
Aberrant amino acid metabolism is a common event in obesity. Particularly, subjects with
obesity are characterized by the excessive plasma kynurenine (Kyn). However, the primary …
obesity are characterized by the excessive plasma kynurenine (Kyn). However, the primary …
[HTML][HTML] Immunoediting instructs tumor metabolic reprogramming to support immune evasion
CH Tsai, YM Chuang, X Li, YR Yu, SF Tzeng, ST Teoh… - Cell metabolism, 2023 - cell.com
Immunoediting sculpts immunogenicity and thwarts host anti-tumor responses in tumor cells
during tumorigenesis; however, it remains unknown whether metabolic programming of …
during tumorigenesis; however, it remains unknown whether metabolic programming of …
The uniqueness of tryptophan in biology: properties, metabolism, interactions and localization in proteins
S Barik - International journal of molecular sciences, 2020 - mdpi.com
Tryptophan (Trp) holds a unique place in biology for a multitude of reasons. It is the largest
of all twenty amino acids in the translational toolbox. Its side chain is indole, which is …
of all twenty amino acids in the translational toolbox. Its side chain is indole, which is …
IDO/kynurenine pathway in cancer: possible therapeutic approaches
EE Abd El-Fattah - Journal of Translational Medicine, 2022 - Springer
Cancer is one of the leading causes of death in both men and women worldwide. One of the
main changes associated with cancer progression, metastasis, recurrence, and …
main changes associated with cancer progression, metastasis, recurrence, and …
Paraptosis inducer to effectively trigger immunogenic cell death for metastatic tumor immunotherapy with IDO inhibition
RR Zheng, LP Zhao, CY Huang, H Cheng, N Yang… - ACS …, 2023 - ACS Publications
Paraptosis is characterized by the extensive vacuolization of endoplasmic reticulum (ER)
and mitochondria, which will cause the release of damage-associated molecular patterns to …
and mitochondria, which will cause the release of damage-associated molecular patterns to …
Indoleamine 2, 3‐dioxygenase 1 (IDO1): an up‐to‐date overview of an eclectic immunoregulatory enzyme
MT Pallotta, S Rossini, C Suvieri, A Coletti… - The FEBS …, 2022 - Wiley Online Library
Indoleamine 2, 3‐dioxygenase 1 (IDO1) catalyzes the initial rate‐limiting step in the
degradation of the essential amino acid tryptophan along the kynurenine pathway. When …
degradation of the essential amino acid tryptophan along the kynurenine pathway. When …